Table 16 Subgroup analysis for study design (ITT vs. completers’ analysis)
Author | Year | Drug | Verum | Placebo | ||
|---|---|---|---|---|---|---|
| Â | Participants | Responders | Participants | Responders | ||
Group A: Analyses by ITT | ||||||
Costa | 1985 | Mianserin | 36 | 28 | 37 | 18 |
Van Heeringen | 1996 | Mianserin | 28 | 19 | 27 | 10 |
Musselmann | 2006 | Paroxetine/desipramine | 24 | 11 | 11 | 6 |
Total | Â | Â | 88 | 58 | 75 | 34 |
Group B: analyses not by ITT | ||||||
Fisch | 2003 | Fluoxetine | 64 | 31 | 65 | 23 |
Razavi | 1996 | Fluoxetine | 45 | 8 | 46 | 9 |
Total | Â | Â | 109 | 39 | 111 | 32 |